Alvogen Appoints CFO
This article was originally published in Scrip
Kevin Bain, who was recently Alvogen's chief financial officer (CFO), has been appointed CFO of its biotech sister company, Alvotech. He will continue as executive vice-president of strategic development at Alvogen where Graham Baker has been appointed the new CFO - effective Nov.1, 2015. Prior to Alvogen, Baker spent 20 years' at AstraZeneca where he was most recently vice-president of finance for the company's international business.